Table 2 Disclosures of the CanPainSCI CPG group.

From: The CanPain SCI clinical practice guidelines for rehabilitation management of neuropathic pain after spinal cord injury: 2021 update

Member

Disclosures

ARA

ARA has nothing to disclose.

DJA

DJA has nothing to disclose.

BB

BB has nothing to disclose

TNB

TNB has nothing to disclose.

SG

SG has nothing to disclose.

TJ

TJ is employed by the Ontario Neurotrauma Foundation.

AK-D

AK-D has nothing to disclose.

DK

DK has nothing to disclose.

OL

OL has nothing to disclose.

GL-T-F

GL-T-F has nothing to disclose.

EL

EL has nothing to disclose.

SM

SM has nothing to disclose.

MM

MM has nothing to disclose.

DEM

DEM reports personal fees from Canopy Growth Inc, outside the submitted work.

CO’C

CO’C reports grants from Praxis Spinal Cord Institute, other from Cytokinetics, other from Orion, other from Mallinckrodt, grants from New Brunswick Health Research Foundation, personal fees from Spectrum/Canopy, personal fees from Shoppers Drug Mart, grants and personal fees from IPSEN, personal fees from MT Pharma, personal fees from Tilray, personal fees from Allergan, personal fees from Roche, outside the submitted work.

SO

SO has nothing to disclose.

PP

PP has nothing to disclose.

JWM

JWM has nothing to disclose.

CS MD

CS has nothing to disclose.

RT

RT reports other funding from Allergan (Predictive Model for Treatment of Spasiticity Post Stroke (Botox), chair positions on data monitoring/advisory boards for studies on statins for osteoporosis after SCI and exercise in SCI, and medicolegal work for assessment of individuals with whiplash and other musculoskeletal injuries after motor vehicle accidents outside the submitted work.

AT

AT has nothing to disclose.

EW-N

EW-N has nothing to disclose.

DLW

DLW has nothing to disclose.

NX

NX has nothing to disclose.